About BEAM™
BEAM™ is a powerful diagnostic tool that combines EEG (electroencephalogram) brainwave analysis with advanced neurocognitive testing to provide a comprehensive picture of brain function. Using a large normative database, BEAM™ computes key biomarkers that help identify specific types of dementia, track the progression of cognitive decline, and evaluate how well a treatment is working over time.
Available at Alzheimer’s Treatment Centers of America (ATCA), BEAM™ is part of our commitment to precision medicine—offering a more detailed, personalized approach to diagnosing and managing Alzheimer’s and other forms of dementia.
Frequently Asked Questions
What is BEAM™ and how does it work?
Why is BEAM™ important for diagnosing dementia?
What happens during a BEAM™ assessment?
Can BEAM™ track changes over time?
Is BEAM™ covered by insurance?
BEAM™ assessments may be covered by insurance depending on your plan and medical necessity. Our care team at ATCA will help you determine eligibility and coverage options.
